SCH 697243

SCH 697243 · ALK-Abelló A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCH 697243, covering 2013-09-10 to 2013-09-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) [Phase 3]

See pricing